Targeting melanoma, lymphoma: Study finds investigational compound active against cancer driven by genetic mutation
Norman Sharpless, MD, and colleagues reported in Nature Medicine findings from a preclinical study that demonstrated that a potential new drug effectively targeted a genetic mutation linked to melanoma and the most common form of lymphoma.
Superior Court Judge Carl Fox hosted a “UNC Heroes” fundraising event for the Leukemia and Lymphoma Society on Sunday, April 24 in Carrboro, NC. Judge Fox was appointed as the first black District Attorney in North Carolina in 1984 and became Senior Superior Court Judge in 2005. He was diagnosed in 2015 with a type of blood cancer called myelodysplastic syndrome.
A study, authored by UNC Lineberger member Stacie Dusetzina, PhD, found that oral cancer drugs introduced in 2014 were, on average, six times more expensive than those introduced in the year 2000. The findings, published in JAMA Oncology, raised concerns as patients may increasingly take on the cost burden of those increases.
UNC Lineberger member Satish Gopal, MD, MPH, has called for a commitment to contribute resources and energy to control cancer in less-resourced countries where there are significant gaps in cancer awareness, prevention, diagnosis, and treatment.